Discover 491 paid clinical trials in Warwick, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 491
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Peroneal Electrical Nerve Stimulation in Pregnancy for Restless Legs Syndrome
for
Restless Leg Disorder, Restless Leg Syndrome (RLS), Pregnancy,
Location: Providence RI
Sponsor: Rhode Island Hospital
Sex: Female
Age: 18+
Code: NCT07144631
Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Providence RI, Worcester MA, Boston MA, Hartford CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase 3, Recruiting
Emergency Medicine Peer Outreach Worker Engagement for Recovery
for
Substance Use Disorders, Overdose, Opioid Use Disorder,
Location: Providence RI
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT06320015
Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for
Coronary Arterial Disease (CAD),
Location: Providence RI, Boston MA, Roslyn NY, The Bronx NY,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06959524
Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Providence RI, Boston MA, The Bronx NY, Wilkes-Barre PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase 2, Recruiting
Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass
for
Pulmonary Hypertension
Location: Providence RI, Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT07132788
Recruiting
Opioid Management for Discharged Emergency Department Patients
for
Bone Fractures
Location: Providence RI
Sponsor: Addinex Technologies, Inc.
Sex: All
Age: 6+
Code: NCT06592378
Recruiting
Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well
for
Acute Ischemic Stroke
Location: Providence RI, Morgantown WV, Chicago IL, St Louis MO,
Sponsor: Amrou Sarraj
Sex: All
Age: 18 - 70+
Code: NCT07115940
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for
Prostate Cancer (Adenocarcinoma)
Location: Providence RI, West Haven CT, The Bronx NY, Lebanon NH,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06592924
Phase 3, Recruiting
A Sleep Hygiene Intervention to Improve Sleep Health in Urban, Latino Middle School Children
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Providence RI, Worcester MA, Boston MA, Hartford CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase 2, Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
for
Respiratory Insufficiency,
Location: Providence RI, New York NY, Philadelphia PA, Sherbrooke,
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT05440851
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
for
Atrial Fibrillation
Location: Providence RI, Boston MA, Burlington MA, Stony Brook NY,